About Vivos Inc. Vivos Inc. is a clinical-stage medical device company developing RadioGel ®, a precision radiotherapy hydrogel for human and veterinary oncology applications. IsoPet ® is commercially ...
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today ...
I’m holding off on Botox for now, and I am quite the holdout. At 45 years old, I’m the last one of my friends or coworkers to give the neuromodulator a shot (pun intended), and many women get ...
JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio ® in healthy adult participants, met all its primary endpoints REYKJAVIK, Iceland, ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Hannah Morrill Hannah Morrill is an editor covering gifts and beauty. After ...
The table below is a review of notable updates that occurred in January 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.
We explore the FDA’s expansion of Wakix as the first non-scheduled treatment for pediatric cataplexy; a Taltz and Zepbound combo shows promise in skin clearance for patients with psoriasis and obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results